Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients.
暂无分享,去创建一个
F. Sack | T. Dengler | R. Zimmermann | W. Kübler | O. Girgsdies | J. Meyer
[1] Y. Shoenfeld,et al. Vaccine-induced autoimmunity. , 1996, Journal of autoimmunity.
[2] O. Girgsdies,et al. Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study. , 1996, Vaccine.
[3] F. Hayden,et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] L. Lindquist,et al. A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy. , 1996, Scandinavian journal of infectious diseases.
[5] K. Theobald,et al. Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events. , 1995, Vaccine.
[6] A. Teufel,et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. , 1994, The Journal of rheumatology.
[7] W. Petri,et al. Infections in heart transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] C. Dioudis,et al. Influenza vaccination on renal transplant patients is safe and serologically effective. , 1993, International journal of clinical pharmacology, therapy, and toxicology.
[9] J. Kobashigawa,et al. Influenza vaccine does not cause rejection after cardiac transplantation. , 1993, Transplantation proceedings.
[10] P. Whitington,et al. Measles vaccination after orthotopic liver transplantation. , 1993, The Journal of pediatrics.
[11] M. D. de Broe,et al. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. , 1993, Vaccine.
[12] M. Eibl,et al. Cellular and humoral immune responses in haemophiliacs after vaccination against tick‐borne encephalitis , 1992, British journal of haematology.
[13] U. Klockmann,et al. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. , 1992, Vaccine.
[14] W. Carey,et al. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. , 1990, The American journal of gastroenterology.
[15] M. Hammond,et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.
[16] U. Klockmann,et al. A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study. , 1990, Vaccine.
[17] W. Graninger,et al. Infectious complications in heart transplant recipients with combined low dose cyclosporine, azathioprine and prednisolone (triple drug) immunosuppression. , 1989, Transplantation proceedings.
[18] U. Klockmann,et al. Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine. , 1989, Journal of biological standardization.
[19] M. Eibl,et al. Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy , 1986, Cancer.
[20] F. Heinz,et al. A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. , 1983, Virology.
[21] F. Heinz,et al. Preparation of a highly purified vaccine against tick‐borne encephalitis by continuous flow zonal ultracentrifugation , 1980, Journal of medical virology.
[22] F. Heinz,et al. Immunogenicity and reactogenicity of a highly purified vaccine against tick‐borne encephalitis , 1980, Journal of medical virology.